Buy or sell Kaleido BioSciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

View More Companies

Kaleido BioSciences Stock

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

About Kaleido BioSciences Stock

Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.

Funding History

August 2015$4.5M
September 2017$60.0M
June 2018$101M

Press

Other Companies

Baxter International Logo
Learn More
Learn More
Baxter International
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people.
89Age (years)
$0Total Funding
Nabi Biopharmaceuticals Logo
Learn More
Learn More
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.
53Age (years)
$10.0MTotal Funding
Quanterix Logo
Learn More
Learn More
Quanterix
Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.
13Age (years)
$90.0MTotal Funding
TP Therapeutics Logo
Learn More
Learn More
TP Therapeutics
TP Therapeutics is a structure-based drug design pharmaceutical company
6Age (years)
$144MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kaleido BioSciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo